Case Report
Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis
Table 2
Disease activity of RA at baseline and follow-up period.
| | Baseline | 3 months | 6 months | 12 months | 18 months | 24 months |
| Tender joints (0–28) | 24 | 2 | 2 | 10 | 2 | 1 | Swollen joints (0–28) | 10 | 4 | 0 | 6 | 0 | 0 | ESR (mm/h) | 52 | 3 | 7 | 8 | 7 | 11 | Global Health score (0–100) | 80 | 50 | 40 | 60 | 40 | 60 | DAS28 score | 7.81 | 2.82 | 2.71 | 4.75 | 2.71 | 3.08 | Prednisolone dose (mg/day) | 10 | 2.5 | 2.5 | 2.5 | 0 | 0 |
|
|